Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Christopher G. Mueller"'
Autor:
Victoria N. Cousin, Guillermo F. Perez, Kathryn J. Payne, Reinhard E. Voll, Marta Rizzi, Christopher G. Mueller, Klaus Warnatz
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Non-hematopoietic lymphoid stromal cells (LSC) maintain lymph node architecture and form niches allowing the migration, activation, and survival of immune cells. Depending on their localization in the lymph node, these cells display heterogeneous pro
Externí odkaz:
https://doaj.org/article/a6c59a15684240d5baec61c3f21568fe
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
In the light of the success and the expected growth of its arsenal, immuno-therapy may become the standard neoadjuvant procedure for many cancers in the near future. However, aspects such as the identity, organization and the activation status of the
Externí odkaz:
https://doaj.org/article/24fe603f6808498385130df6205f42d5
Autor:
Bouchra Sojod, Danielle Chateau, Christopher G. Mueller, Sylvie Babajko, Ariane Berdal, Frédéric Lézot, Beatriz Castaneda
Publikováno v:
Frontiers in Physiology, Vol 8 (2017)
Periodontitis is based on a complex inflammatory over-response combined with possible genetic predisposition factors. The RANKL/RANK/OPG signaling pathway is implicated in bone resorption through its key function in osteoclast differentiation and act
Externí odkaz:
https://doaj.org/article/b410e019603542d694ccb2d45933cd86
Autor:
Gertraud Orend, Ellen Van Obberghen-Schilling, Fabienne Anjuère, Anne Sudaka, Shigeyuki Kon, Katja Schenke-Layland, Manuel Koch, Christopher G. Mueller, Hélène Dumortier, Christine Carapito, Aurélie Hirschler, Nicolas Pythoud, Raphael Carapito, Nicodème Paul, Uwe Hansen, Thomas Imhof, Kelly Nouhen, Sebastian Schaub, Samah Rekima, Abdouramane Camara, Vony Randrianarisoa, Gérard Cremel, Eva-Maria Brauchle, Matthias Mörgelin, Pierre Bourdely, Luciana Petti, Romain Veber, Stephanie Beghelli-de la Forest Divonne, William Erne, Devadarssen Murdamoothoo, Thomas Loustau, Caroline Spenlé
Supplemental Figures S1 - S7 Supplemental Tables S1 - S17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63df7bab4dcc75d0081b13cd449f832a
https://doi.org/10.1158/2326-6066.22542310
https://doi.org/10.1158/2326-6066.22542310
Autor:
Gertraud Orend, Ellen Van Obberghen-Schilling, Fabienne Anjuère, Anne Sudaka, Shigeyuki Kon, Katja Schenke-Layland, Manuel Koch, Christopher G. Mueller, Hélène Dumortier, Christine Carapito, Aurélie Hirschler, Nicolas Pythoud, Raphael Carapito, Nicodème Paul, Uwe Hansen, Thomas Imhof, Kelly Nouhen, Sebastian Schaub, Samah Rekima, Abdouramane Camara, Vony Randrianarisoa, Gérard Cremel, Eva-Maria Brauchle, Matthias Mörgelin, Pierre Bourdely, Luciana Petti, Romain Veber, Stephanie Beghelli-de la Forest Divonne, William Erne, Devadarssen Murdamoothoo, Thomas Loustau, Caroline Spenlé
Inherent immune suppression represents a major challenge in the treatment of human cancer. The extracellular matrix molecule tenascin-C promotes cancer by multiple mechanisms, yet the roles of tenascin-C in tumor immunity are incompletely understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23697c2938fb3e00969dd77509d68ef5
https://doi.org/10.1158/2326-6066.c.6549868.v1
https://doi.org/10.1158/2326-6066.c.6549868.v1
Autor:
Janina Sponsel, Yubing Guo, Lutfir Hamzam, Alice C Lavanant, Annia Pérez‐Riverón, Emma Partiot, Quentin Muller, Julien Rottura, Raphael Gaudin, Dirk Hauck, Alexander Titz, Vincent Flacher, Winfried Römer, Christopher G Mueller
Publikováno v:
EMBO reports. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d70b408c7f14f847d7e354f9da4748cf
https://doi.org/10.15252/embr.202255971
https://doi.org/10.15252/embr.202255971
Autor:
Florent Arbogast, Raquel Sal-Carro, Wacym Boufenghour, Quentin Frenger, Delphine Bouis, Louise Filippi De La Palavesa, Jean-Daniel Fauny, Olivier Griso, Hélène Puccio, Rebecca Fima, Thierry Huby, Emmanuel L. Gautier, Anne Molitor, Raphaël Carapito, Seiamak Bahram, Nikolaus Romani, Björn E. Clausen, Benjamin Voisin, Christopher G. Mueller, Frédéric Gros, Vincent Flacher
Macroautophagy (often-named autophagy), a catabolic process involving autophagy-related (Atg) genes, prevents accumulation of harmful cytoplasmic components and mobilizes energy reserves in long-lived and self-renewing cells. Autophagy deficiency aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ffbb3dada08fdb95f07775d9361bb3c
https://hal.science/hal-03854519
https://hal.science/hal-03854519
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2020, 36 (10), pp.835-838. ⟨10.1051/medsci/2020148⟩
médecine/sciences, EDP Sciences, 2020, 36 (10), pp.835-838. ⟨10.1051/medsci/2020148⟩
International audience; No abstract available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a576ecfaac7efac9d387479b096d9278
https://doi.org/10.1051/medsci/2020148
https://doi.org/10.1051/medsci/2020148
Autor:
Abdouramane Camara, Alice C. Lavanant, Jun Abe, Henri Lee Desforges, Yannick O. Alexandre, Erika Girardi, Zinaida Igamberdieva, Kenichi Asano, Masato Tanaka, Thomas Hehlgans, Klaus Pfeffer, Sébastien Pfeffer, Scott N. Mueller, Jens V. Stein, Christopher G. Mueller
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance The CD169+ macrophages that play an important role in the fight against infections and cancer are receptive to environmental signals for their differentiation. We show that lymph node and splenic CD169+ macrophages require both LTβR and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6172aaf279de6038ce72fa8abed23989
http://www.pnas.org/lookup/doi/10.1073/pnas.2108540119
http://www.pnas.org/lookup/doi/10.1073/pnas.2108540119
Autor:
Marina Pierrevelcin, Vincent Flacher, Christopher G. Mueller, Romain Vauchelles, Eric Guerin, Benoît Lhermitte, Erwan Pencreach, Andreas Reisch, Quentin Muller, Layal Doumard, Wacym Boufenghour, Andrey S. Klymchenko, Sophie Foppolo, Charlotte Nazon, Noelle Weingertner, Sophie Martin, Claire Briandet, Véronique Laithier, Antonio Di Marco, Laurent Bund, Adeline Obrecht, Pascal Villa, Monique Dontenwill, Natacha Entz‐Werlé
Publikováno v:
Advanced Healthcare Materials. 11:2200195
Osteosarcoma (OS) is the most common primary bone cancer, where the overall 5-year surviving rate is below 20% in resistant forms. Accelerating cures for those poor outcome patients remains a challenge. Nevertheless, several studies of agents targeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7937e9dcd8b389595e8c8794d9c7393
https://doi.org/10.1002/adhm.202200195
https://doi.org/10.1002/adhm.202200195